Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add‐on β‐blockade

[1]  D. Tepper.  Frontiers in congestive heart failure: Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). , 1999, Congestive heart failure.

[2]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[3]  H. Crijns,et al.  Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables , 1999, Heart.

[4]  J. Sanderson,et al.  Effect of β-blockade on baroreceptor and autonomic function in heart failure , 1999 .

[5]  J G Turner,et al.  Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction , 1999, Heart.

[6]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[7]  A. Hall,et al.  β Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study , 1999, Heart.

[8]  J. Sanderson,et al.  Effect of beta-blockade on baroreceptor and autonomic function in heart failure. , 1999, Clinical science.

[9]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[10]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[11]  F Boomsma,et al.  Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. , 1996, Journal of the American College of Cardiology.

[12]  J. Le Heuzey,et al.  Effects of bisoprolol on heart rate variability in heart failure. , 1996, The American journal of cardiology.

[13]  G. Grassi,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.

[14]  P. Binkley,et al.  Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. , 1995, Circulation.

[15]  H. Crijns,et al.  Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. , 1994, British heart journal.

[16]  C. Lang,et al.  QT dispersion and sudden unexpected death in chronic heart failure , 1994, The Lancet.

[17]  J. Cohn,et al.  Mechanism of Death in Heart Failure The Vasodilator‐Heart Failure Trials , 1993, Circulation.

[18]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[19]  M. Packer.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[20]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[21]  Y. Imai,et al.  Circadian blood pressure variations under different pathophysiological conditions. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[22]  D. Ewing,et al.  Immediate heart rate response to lying down: simple test for cardiac parasympathetic damage in diabetics. , 1983, British medical journal.

[23]  F. Smedes,et al.  Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. , 1982, Journal of chromatography.

[24]  D. Hosmer,et al.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. , 1973, American heart journal.

[25]  J. Naughton,et al.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. , 1972, The American journal of cardiology.